american diabetes association pancreatitis glp-1 receptor agonist history The Use of Glucagon-like Peptide-1 Agonists in Patients with Type 2 Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study This review summarizes how GLP-1

Vitamin D supplementation guidelines for the general population and groups at risk of vitamin D deficiency in PolandRecommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies2018 update

& Pomerantz, J

Ayoubi M, Thomas DA, Kantarjian H, O'Brien S, Ravandi F, Garcia-Manero G, Verstovsek S, Rytting M, Borthakur G, Kadia T, Kornblau SM, Andreeff M , Feliu J, Faderl S

Traditional discovery pipelines, reliant on iterative ligand modifications and empirical screening, are resource-intensive and serendipitous

They can be used in conjunction with other anti-diabetic drugs, such as SGLT-2 inhibitors [7]